Research Analysts Set Expectations for BCAX FY2026 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Equities research analysts at HC Wainwright issued their FY2026 EPS estimates for Bicara Therapeutics in a research report issued on Friday, May 16th. HC Wainwright analyst R. Burns expects that the company will post earnings per share of ($2.59) for the year. HC Wainwright currently has a […]
